Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K SignalingXin-Qun Chai, Shanmiao Gou|Scientific Reports|2015Cited by 71